title: Who to screen for calreticulin mutations? An audit of real-life practice and review of current evidence.
authors.affiliation: Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland.
authors.forename: Karl
authors.initials: K
authors.lastname: Haslam
authors.affiliation: Cancer Molecular Diagnostics, St. James's Hospital, Dublin, Ireland. Electronic address: slangabeer@stjames.ie.
authors.forename: Stephen E
authors.initials: SE
authors.lastname: Langabeer
mesh_terms: D037282:Calreticulin / Q000235:genetics*; D004252:DNA Mutational Analysis; D005820:Genetic Testing; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D009154:Mutation; D011087:Polycythemia Vera / Q000235:genetics*; D055728:Primary Myelofibrosis / Q000235:genetics*; D013920:Thrombocythemia, Essential / Q000235:genetics*
chemical_list: C576483:CALR protein, human; D037282:Calreticulin; C507924:JAK2 protein, human; D053614:Janus Kinase 2
keywords: CALR; Erythrocytosis; Essential thrombocythemia; Myeloproliferative neoplasms; Primary myelofibrosis; Thrombosis